If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com).  The website is updated approximately twice a month.

PDP Press Releases/ statements

IAVI

• 10 Oct: IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Commercialization, and Access to Vaccines and Antibodies in Africa

 • 23 Oct: Dedication, not defeat

 • 23 Oct: Of all the moments for science to slow down, this is not it.’

• 30 Oct: IAVI calls for innovative partnerships to sustain vaccine development at the World Vaccine Congress Europe 2025

IVCC

 • 19 Aug: World Mosquito Day 2025: A new world, crises, and opportunities

TB Alliance

• 6 Oct: DR-TB regimen will save 190,000+ additional lives and $1.29B by 2035

• 9 Oct: TB Alliance Launches Upskill TB Platform in Collaboration with Indonesia’s Ministry of Health and RPRI Foundation

GARDP 

• 18 Aug: Japan commits new funding to develop treatments for drug-resistant infections

Population Council

PATH

 • 23 Oct: PATH joins WHO’s Global Clinical Trials Forum

MMV

• 6 Oct: First patient enrolled in historic Phase 3 clinical trial to treat malaria in first-trimester pregnancy

• 7 Oct: Coartem® Baby launches in Ghana

• 13 Oct: MMV joins WHO-led Global Clinical Trials Forum as part of its commitment to equitable and inclusive research

• 27 Oct: In memory of Professor Jean Louis Abdourahim Ndiaye

DNDi

• 4 Nov: European Commission invests EUR 20 million to develop urgently-needed medicines against dengue in partnership with AFD and DNDi

FIND

•  8 Sep: FIND’S leadership and impact in Lassa fever diagnostics to feature at 2nd Lassa fever International conference

•  11 Sep: FIND announces appointment of Dr Jutta Reinhard-Rupp as Chief Scientific Officer

•  12 Sep: FIND appoints Henri Mwaniki as Chief Financial Officer

IVI

• 13 Oct: IVI joins WHO’s new Global Clinical Trials Forum

EVI

• 14 Aug: EVI begins clinical trial for promising malaria vaccine in Burkina Faso

MDGH

• 8 Sep: Medicines Development for Global Health announces inclusion of moxidectin on World Health Organization Essential Medicines Lists

PDP Funder News/Announcements

• 3 Oct: The Global Fund works—these stories remind us why it’s essential. Gates Foundation

• 5 Oct: Advancing new and underused innovations to end preventable death in childbirth. Unitaid

• 17 Oct: Ambassador Anne Claire Amprou appointed new Chair of Unitaid’s Executive Board. Unitaid

• 23 Oct: Unitaid to improve access to diagnostics through integrated tools and delivery approaches with new call for proposals. Unitaid

• 29 Oct: Total Investment of Approx. USD 11.6 Million in TB and NTD R&D projects with Partners including FUJIFILM, Stop TB Partnership, and the Ohio State University. GHIT

Funder Announcement Archives

     •     2014 PDP Funder Announcements

     •     2013 PDP Funder Announcements

New PDP Publications

•  25 Apr: Rethinking antibodies for infectious diseases?. IAVI

Other Reports/ Publications

• 4 Nov: More From Less: Optimising Vaccines in a Constrained World. CGD

• 7 Oct: Innovative Financing for Infectious Diseases in South and Southeast Asia. AVPN

• 9 Oct: 2026 Index Methodology zeroes in on scalable actions capable of delivering lasting impact for more people. Access to Medicines Foundation

• Oct: Forecasting global demand for novel TB vaccines: scenarios for early planning and needs assessment. Gavi & CHAI

• 13 Oct: No eradication without innovation: the EU at a crossroads to eliminate HIV/AIDS, TB, and malaria. Global Health Advocates

• 20 Oct: THE PRICE OF RETREAT How underinvestment in malaria risks resurgence, lost growth, and a generation’s future. ALMA et al.

Related Press Releases/ Announcements/Articles

• 1 Nov: A global health expert on Covid’s lessons — and warnings — for the future. STAT

• 2 Oct: WHO releases new reports on new tests and treatments in development for bacterial infections. WHO

• 2 Oct: Analysis of antibacterial agents in clinical and preclinical development: overview and analysis 2025. WHO

• 2 Oct: Broader access urged for affordable HIV drug. SciDevNet

• 2 Oct: Babies' deaths in Cameroon show how US aid cuts curtail malaria fight. Reuters

• 2 Oct: New study shows all-in-one coronavirus vaccines could save millions of lives in future pandemics. CEPI

• 2 Oct: WHO says the antibacterial pipeline reveals a dual crisis: scarcity and lack of innovation. STAT

• 3 Nov: From Warp Speed to COVAX: An insider’s story. Politico

• 3 Oct: Reports identify weakness in global pipeline for new antibiotics, diagnostics. CIDRAP

• 3 Oct: WHO: Conditions ripe for further chikungunya spread. CIDRAP

• 3 Oct: Why Ending Malaria Depends on Bold Financing and Global Leadership. Health Policy Watch

• 3 Oct: In the maraña of leishmaniasis. The Lancet Infectious Diseases

• 3 Oct: From Promise To Practice: Delivering On The WHO Pandemic Agreement. Health Affairs

• 3 Oct: The Pandemic Fund and the Next Global Health Crisis. Observer Research Foundation

• 3 Oct: Comparison of major, minor and junctional circumsporozoite protein epitopes for malaria vaccine design. Nature Vaccines

• 3 Oct: Ghana launches Coartem 'baby' to strengthen fight against malaria in infants. Modern Ghana

• 3 Oct: Operationalizing African self-reliance in vaccine manufacturing. Global Health Action

• 3 Oct: AVAC Input for Recompetition of the NIAID HIV/AIDS Clinical Trials Networks. AVAC

• 4 Nov: Countries Criticise ‘Inadequate’ Pathogen-Sharing Draft Annex at Start of Text-Based Talks. Health Policy Watch

• 4 Nov: Smarter Vaccine Doses: A High-Impact Fix for Global Immunization. CGD

• 5 Oct: Tailoring malaria control interventions to suit local context: codesign of perennial malaria chemoprevention (PMC) programmes through the Plus Project. BMJ

• 6 Oct: First lenacapavirs prequalified. WHO

• 6 Oct: How research access drives public health innovation. Springer Nature

• 6 Oct: CEPI backs new research into vaccines against multiple deadly filoviruses. CEPI

• 6 Oct: Helen Clark named as new Chair of the Gavi Board. Gavi

• 6 Oct: 2024 was a record-setting year for lifesaving vaccines. Vox

• 6 Oct: Mali Enrols First Pregnant Patient in Malaria Trial. Health Policy Watch

• 6 Oct: The role of outdoor mosquito management in malaria control. Devex

• 6 Oct: The global health landscape will never be the same — and it shouldn’t be. Devex

• 6 Oct: Permethrin-treated wraps cut malaria rates in babies by 66%. CIDRAP

• 6 Oct: The Fallout From the Dismantling of USAID Continues. Newsweek

• 6 Oct: The AMR Panel Playbook: Eight Lessons for Building an Independent Panel on Antimicrobial Resistance. CGD

• 6 Oct: Unpacking the US’s New Global Health Strategy: Retreating When We Could Be Winning. CGD

• 7 Oct: Promise and gaps in America First strategy for global health. BMJ

• 7 Oct: Ghanaian Newborns First to Get New Malaria Medication. Health Policy Watch

• 7 Oct: CEPI partners with AVAREF to boost clinical trial application reviews in Africa. CEPI

• 7 Oct: The rise of ‘nightmare bacteria’: antimicrobial resistance in five charts. Nature

• 7 Oct: The Emerging Resistance Index: tracking early resistance to new antibiotics. The Lancet

• 7 Oct: Household transmission of mpox in Africa: limited in adults but more prevalent in children. The Lancet

• 7 Oct: Xpert-Ultra for diagnosing asymptomatic tuberculosis. The Lancet

• 7 Oct: Long-term risk of tuberculosis among individuals with Xpert Ultra trace screening results in Uganda: a longitudinal follow-up study. The Lancet

• 7 Oct: WHO launches the Global Clinical Trials Forum. WHO

• 7 Oct: Babies take a lesson from soldiers in the war against malaria. NPR

• 8 Oct: WHO says Ebola outbreak in Congo shows signs of containment with no new cases reported. Reuters

• 8 Oct: Genetic diversity and natural selection of circumsporozoite surface protein in Vietnam Plasmodium falciparum isolates. Malaria Journal

• 8 Oct: The path from early- to late-liver stage arresting genetically attenuated parasites as a malaria vaccination strategy. Nature Vaccines

• 8 Oct: Safety and pharmacokinetics of dolutegravir dispersible tablets and oral films in term neonates exposed to HIV in South Africa (PETITE-DTG study): an open-label, randomised, phase 1/2 trial. The Lancet HIV

• 8 Oct: Dolutegravir in neonates: finally we are getting there!. The Lancet HIV

• 8 Oct: Stronger, faster, fairer: making mpox vaccines accessible. CEPI

• 8 Oct: Randomized Trial of Targeted Indoor Spraying to Prevent Aedes-Borne Diseases. NEJM

• 8 Oct: ‘Bluetoothing’: Blood-Sharing Drug Trend Fuels Alarming Global H.I.V. Surge. The New York Times

• 8 Oct: UK launches new aid inquiry in response to 40% budget cut. Devex

• 9 Oct: Africa must lead its own health research revolution. SciDevNet

• 9 Oct: The impact of cuts in the US President's Emergency Plan for AIDS Relief funding for HIV pre-exposure prophylaxis in sub-Saharan Africa: a modelling study. Lancet HIV

• 9 Oct: Elucidated protein structures in the malaria parasite offer opportunities for new vaccines. MedicalXpress

• 9 Oct: Pharma’s shift away from infectious disease research could spell disaster for the world’s poorest people. STAT

• 9 Oct: In Kaduna, Nigeria, all hands are on deck to fight an mpox outbreak. Gavi

• 9 Oct: The six-monthly anti-HIV jab is coming. But can SA keep track of millions of users?. BHEKISISA

• 9 Oct: US aid cuts are being felt across Africa. Here’s where.. The Washington Post

• 9 Oct: Ebola vaccine safe for mothers and infants. Nature

• 9 Oct: China joining COVAX boosts bid to ensure fair access to vaccine - GAVI tells Reuters. Reuters

• 10 Oct: Looming Malaria Drug Resistance Spurs Global Search for New Treatments. Health Policy Watch

• 10 Oct: Rapid diagnostics test can detect asymptomatic malaria cases. Imperial College

• 10 Oct: Major foundation pauses grants to US, citing unclear policy changes. Devex

• 10 Oct: Statement on the Launch of African Manufacturing Market Intelligence & Network Analysis (AMMINA). Africa CDC

• 10 Oct: Decolonising women’s health innovation. The BMJ

• 11 Oct: Two for two: lenacapavir during pregnancy and lactation. The Lancet

• 11 Oct: CDC battered by government shutdown firings, while some are rescinded. STAT

• 12 Oct: BMJ Group launches global call to close the women’s health gap and transform innovation. BMJ Group

• 12 Oct: BMFTR boosts international vaccine initiative CEPI. CEPI

• 13 Oct: WHO warns of widespread resistance to common antibiotics worldwide. WHO

• 13 Oct: A new antibiotic is positive news—but it will take more to stay ahead of superbugs. BMJ

• 13 Oct: Innovation in medicines for global health: a 20-year landscape analysis. Nature Drug Discovery

• 13 Oct: Sharp global rise in antibiotic-resistant infections in hospitals, WHO finds. The Guardian

• 13 Oct: EIB and European Commission join forces with BioNTech to build a sustainable vaccine ecosystem in Africa. Science Business

• 13 Oct: How do recurrent malaria infections occur in clinical cohorts: a mathematical modelling study to support study planning. Malaria Journal

• 13 Oct: Germany commits €1B to Global Fund as aid cuts shape World Health Summit. Devex

• 13 Oct: Foreign Aid Is Mostly Gone. It Could Be Replaced With Something Better. The New York Times

• 13 Oct: Antimicrobial resistance, equity and justice in low- and middle-income countries: an intersectional critical interpretive synthesis. Nature

• 14 Oct: CEPI announces new partnership with Indian vaccine maker. CEPI

• 14 Oct: One in Six Bacterial Infections Is Antibiotic Resistant; Calls for Stronger Real-Time Pandemic Risk Surveillance. Health Policy Watch

• 14 Oct: As new infections outpace new drugs, are we sleepwalking into a global health disaster?’. The Guardian

• 14 Oct: BioNTech's African mRNA vaccine production push gets EU funding boost. Fierce Pharma

• 14 Oct: Novo Nordisk Foundation pledges up to $31M to support AI-powered pandemic preparedness platform. Fierce Biotech

• 14 Oct: Report proposes new framework to prepare for future pandemics. CIDRAP

• 14 Oct: POST introduction evaluation (PIE) of the malaria vaccine introduced in three pilot countries (Ghana, Kenya, and Malawi) in 2021. Malaria Journal

• 14 Oct: Africa imports over 70% of its medicines. Making active ingredients locally would change this. Gavi

• 14 Oct: Serum Institute of India and CEPI supercharge pandemic response preparedness targeting H5N1. CEPI

• 14 Oct: Stop playing catch-up with superbugs: the anticipatory governance of antimicrobial resistance. WEF

• 15 Oct: Forecasting global demand for life-saving TB vaccines. CHAI

• 15 Oct: Antimalarial resistance deserves higher priority in global AMR strategy. Oxford Centre for Tropical Medicine & Global Health

• 15 Oct: Haphazard US CDC staff cuts leave questions around impact. Devex

• 16 Sep: Turning Against Vaccines, America Is a Global Outlier. The New York Times

• 16 Oct: Low-cost vaccine vial monitors damaging heat exposure brought to market. MedicalXpress

• 16 Oct: Chikungunya, spreading fast this year, visits Mombasa for a third time. Gavi

• 16 Oct: The US and Europe have cut billions in health aid — can anyone fill the gap?. Nature

• 16 Oct: Global Health Leaders Urge Fewer Agencies Amid Funding Crisis. Health Policy Watch

• 16 Oct: Machine learning advances drug discovery through generalizable models. News Medical

• 16 Sep: NIH funds new center focused on preventing drug-resistant infections. CIDRAP

• 17 Oct: Drive to include pregnant and breastfeeding women and children in clinical trials. Health Policy Watch

• 17 Oct: New Monoclonal Antibody Shows Promise for Preventing Malaria Infections. Newswise

• 17 Oct: Physicians’ knowledge of, and willingness to encourage caregivers to partake in the RTS S/AS01 and R21 matrix M malaria vaccines roll out – a national survey in Nigeria. BMC Infectious Diseases

• 17 Oct: Africa CDC chief: 60% of foreign health aid was effectively wasted. Devex

• 18 Oct: Preserving clinical skills in the age of AI assistance. The Lancet

• 18 Oct: New monoclonal antibody prevents malaria infection in early clinical trial. MedicalXpress

• 19 Oct: Trump is cutting foreign aid. He’s not the only one. Politico

• 20 Oct: True Diagnostics nabs BARDA award of up to $11M for Ebola, Marburg fingerstick rapid test. 360Dx

• 20 Oct: A simple strategy to cut malaria infection rates in babies. Nature Medicine

• 20 Oct: Can innovative models close financing gaps for neglected disease R&D?. Devex

• 20 Oct: Defunding mRNA vaccine research leaves us all more vulnerable to future health emergencies. BMJ

• 20 Oct: Who should get the first doses of the twice-a-year HIV prevention jab? It could be in 360 clinics by February. Bhekisisa  

• 20 Oct: Are Cabotegravir Injections More Tolerable Than Lenacapavir?. POZ

• 20 Oct: Rethinking global health R&D: a system under pressure, time for reform. Impact for Global Health

• 20 Oct: Insights into malaria parasite's sodium pump structure could reshape treatment. Phys.org

• 21 Oct: Caregivers’ practices and factors associated with malaria vaccine uptake among under-five children in the Tiko Health District, Cameroon: A community based cross-sectional study. PLOS Global Health

• 21 Oct: Malaria Resurgence Could Kill Nearly One Million by 2030 as Funding Cuts Hit. Health Policy Watch

• 21 Oct: 7-year Wellcome grant awarded to advance health research and training in Africa. University of Liverpool

• 21 Oct: Anti-malaria funding cuts could lead to ‘deadliest resurgence ever’, study warns. The Guardian

• 21 Oct: Gilead agrees not to raise prices on HIV medicines for state AIDS drug programs. STAT

• 21 Oct: As aid shrinks, top philanthropies test new ways to spur economic growth. Devex

• 21 Oct: ‘I fear we are sitting on a time bomb.’ Scientists debate mass distribution of antibiotics in Africa. Science

• 21 Oct: Moxidectin combination therapies for lymphatic filariasis—36-month follow-up. The Lancet Infectious Diseases

• 22 Oct: A crisis in malaria treatment is coming — we must act faster to contain it. Devex

• 22 Oct: Global progress against neglected tropical diseases continues despite challenges, new WHO report finds. WHO

• 22 Oct: A shot at survival: Zambia prepares to roll out malaria vaccination. Gavi

• 22 Oct: Spatial repellents could help supercharge the fight against malaria. Forbes

• 22 Oct: How did dengue go global? This mosquito species might be to blame. Georgetown University

• 23 Oct: Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing. Health Policy Watch

• 23 Oct: Africa Seeks More Self-Reliance Amid Disease Outbreaks and Decline in Donor Funds. Health Policy Watch

• 23 Oct: Can Africa’s drug regulators be both fast and trusted?. Devex

• 23 Oct: Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development. Science Direct

• 23 Oct: Inclusion of women who are pregnant, lactating, or of reproductive potential in clinical trials: health, ethical, and regulatory considerations. The Lancet

• 23 Oct: WHO and MPP Launch Phase 2.0 of the mRNA Technology Transfer Programme. Medicines Patent Pool

• 24 Oct: Togo introduces the malaria vaccine: a health milestone. Gavi

• 24 Oct: How HIV research drives health innovation in multiple diseases. Nature

• 24 Oct: WHO Reports 40 Percent Jump in Antibiotic-Resistant infections; BU-Based Nonprofit Leads the Fight Back. Boston University

• 24 Oct: A vaccine visionary reflects: Seth Berkley's global memoir is a shot worth taking. Gavi

• 25 Oct: In Fight Against Malaria, an Unexpected — and Snuggly — Shield. The New York Times

• 25 Oct: Nigeria Launches Project to Prevent Antimalarial Drug Resistance. Voice of Nigeria

• 27 Oct: Private donors gave more than $125M to keep foreign aid programs going after US cuts. AP

• 27 Oct: New Executive Director and CEO to lead NIVI into the next phase of revolutionizing and accelerating vaccine development. NIVI

• 27 Oct: HIV/AIDS research has saved millions of lives globally and led to innovative advances in multiple diseases. Fred Hutch Cancer Center

• 27 Oct: EXCLUSIVE: EU mulls copying US with end to aid for global health funds. Euroactiv

• 27 Oct: Zambia launches malaria vaccine to protect over half million children. Gavi

• 27 Oct: Gavi is leaping into the future: there is no time to lose. Gavi

• 27 Oct: The Guardian view on global aid cuts: a malaria resurgence could be the canary in the coalmine. The Guardian

• 27 Oct: SA becomes the first African country to register the twice-a-year anti-HIV jab — at record speed. Bhekisisa

• 28 Oct: Seth Berkley interview: vaccination in a time of extreme scepticism. BMJ

• 28 Oct: Lenacapavir Regulatory Approval. AVAC

• 28 Oct: Establishing the world’s largest Nipah virus vaccine reserve. CEPI

• 28 Oct: To end TB, time for us to own our disease response and financing for health. Devex

• 28 Oct: WHO Member States Get Skeleton Draft on Pathogen Sharing Ahead of Text-Based Negotiations. Health Policy Watch

• 28 Oct: Transforming HIV Prevention in 2025. AVAC

• 29 Oct: A ‘devil’s choice’ on vaccines and pandemic preparedness. STAT

• 29 Oct: The bat paradox: what nature’s night flyers could teach us about pandemics – and ourselves. Gavi

• 29 Oct: ‘The Great Mimicker’: meet the deadly bacterium spreading worldwide. Gavi

• 29 Oct: Possible EU cuts to HIV and vaccine funding ‘irresponsible’, Global Fund says. Euractiv

• 29 Oct: Global vaccine safety network to launch in six countries across three continents. CEPI

• 30 Oct: How will the new malaria vaccine shape Africa’s economic future?. UK Government

• 30 Oct: Innovations in Sexual and Reproductive Health. The Lancet

• 30 Oct: Access Strategy for Lenacapavir for PrEP in Low- and Middle-Income Countries. Gilead

• 30 Oct: How Moderna, the company that helped save the world, unraveled. STAT

• 31 Oct: Working to Make Africa Attractive for Global Clinical Trials. Health Policy Watch

Upcoming Meetings/  Webinars

--------------------------